Pharmacy Focus: Oncology Edition : Episode 16

Commentary

Podcast

June 27, 2024

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

The PALOMA-3 trial showed subcutaneous amivantamab was better than IV among lung cancer patients.

This month, we spoke with Natasha B. Leighl, BSc, MMSc, MD, Medical Oncologist at the Princess Margaret Cancer Centre in Toronto, Canada. Leighl discussed the PALOMA-3 trial results, shared at the American Society of Clinical Oncology 2024 Conference. Leighl noted that the trial compared subcutaneous and intravenous administration of amivantamab for lung cancer.

EP: 1.Pharmacy Focus: Oncology Edition - A Conversation About Biden's Cancer Moonshot Program

EP: 2.Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer

EP: 3.Pharmacy Focus: Oncology Edition - What You Missed at ASCO 2022

EP: 4.Pharmacy Focus: Oncology Edition - A Look Ahead at the Pipeline for Melanoma

EP: 5.Pharmacy Focus: Oncology Edition - An Update on Prostate Cancer and the Growing Role of Pharmacists

EP: 6.Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia

EP: 7.Pharmacy Focus: Oncology Edition - Pharmacists Play Key Role in Non–Small Cell Lung Cancer

EP: 8.Pharmacy Focus: Oncology Edition - Breast Cancer Treatments Are Rapidly Expanding

EP: 9.Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma

EP: 10.Pharmacy Focus: Oncology Edition - A Look Into Psychedelic Medicines for Oncology Care

EP: 11.Pharmacy Focus: Oncology Edition - PARP Inhibitors Are Changing the Game in Prostate Cancer

EP: 12.Pharmacy Focus: Oncology Edition- A Practical, Real-World Understanding of the Enhancing Oncology Model

EP: 13.Pharmacy Focus: Oncology Edition- Latest Updates in Non-Small Cell Lung Cancer Treatment

EP: 14.Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

EP: 15.Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

Now Viewing

EP: 16.Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

EP: 17.Pharmacy Focus - Oncology Edition: The Link Between Gut Health and Colon Cancer, Exploring the Wellness Innovation Network

EP: 18.Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

EP: 19.Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

EP: 20.Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

EP: 21.Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

EP: 22.Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

EP: 23.The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

EP: 24.From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

EP: 25.Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!